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ABSTRACT 
 
Background:  Tuberculosis is a global epidemic. Drug Resistant Tuberculosis (DR-TB) is a big blow to the 
National Tuberculosis Control Programme. Second line Anti TB drugs are expensive, toxic and weaker drugs than 
First line anti TB drugs. Aims: To study demographic and clinical profile of drug-resistant TB patients in Mumbai. 
Materials and Methods: Data was collected from DR-TB patients attending tertiary care hospital over one year 
period. Observation and Results: Of the 60 cases analyzed, DR-TB mainly affected less than 40 years age group. 
Females were more affected. Of the 60 cases, 42 patients had Pulmonary TB; while 18 patients had extra-pulmonary 
TB. Radiology helped in diagnosis and assesses the response to treatment especially in extra pulmonary TB.  
Conclusion: Drug Resistant Tuberculosis affects the economically productive age-group. Constitutional symptoms 
predominate even in drug resistant tuberculosis. Acquired drug resistance remains the main cause for drug resistant 
tuberculosis in India. Pulmonary drug-resistant TB cases exceed Extra-pulmonary TB cases in urban set up. 
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Introduction 
 
Tuberculosis has been declared as a global epidemic by 
the World Health Organization. Drug Resistant 
Tuberculosis is a global threat to National Tuberculosis 
Control Programme in all countries. Multi-drug 
Resistant Tuberculosis is the strain of mycobacteria 
that is resistant to at least - Isoniazid and Rifampicin – 
the two most important drugs for TB treatment[1,2].
 
The use of molecular methods has increased the yield 
of diagnosis of drug resistant tuberculosis 
exponentially. There is a need to study the profile of 
patients with drug resistant tuberculosis to make earlier 
diagnosis and initiate correct treatment for better 
outcomes. 
_______________________________ 
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Aim & Objectives 
To study the demographic profile of patients with drug 
resistant tuberculosis  
To study the clinical presentation in patients with drug 
resistant tuberculosis  
To study the radiological profile of patients with drug 
resistant tuberculosis 
Methodology 
All patients with Multi-drug Resistant Tuberculosis 
were included in this study conducted over 1 year 
period. Ethics Committee permission was obtained 
from the institute. Written informed consent was 
obtained from all patients. Their detailed demographic, 
clinical and investigations were collected and analyzed 
using Excel sheet and SPSS software. 
Observation & Results 
60 patients were included in this study. These patients 
were referred from various departments of the hospital 
for management of Drug Resistant Tuberculosis. Those 
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patients included in the study were positive for growth 
of Mycobacteria on culture which was resistant to 
Isoniazid and Rifampicin. The following observations 
were noted during analysis of the data collected from 
these patients. 
Table 1: Gender 
 
 
 Frequency Percent 
 Female 38 63.3 
Male 22 36.7 
Total 60 100.0 
 
There was a predominance of female in this group i.e 38 (63.3%) were females as against 22 males (36.7%)[3].
 
 
Graph 1: Age Groups 
90% (54) of the study group were below 40 yrs of age. This was the economically productive group especially worst 
for the sole bread-winner of the family. The youngest in the group was 18-year old. The mean weight in this group 
was 43.2 kg. 
 
Graph 2: Site of Drug Resistant Tuberculosis 
There were 42 cases (70%) of Pulmonary Tuberculosis. While 10 cases (16.7%) were Pott’s Spine 
(Tuberculosis of the Spine). Rest was 2 cases (3.3%) each of Skin & joint, Lymph node, Calcaneal & disseminated 
form of TB.  
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Table 2: Symptoms 
 
 
 
 
 
 
 
 
 
 
 
The predominant symptoms in this group were constitutional symptoms of low grade fever, anorexia and 
weight loss before starting the treatment. (Except 2 patients of lymph node tuberculosis – who did not have these 
symptoms). The next common symptom was cough (63.3%)  (due to predominant pulmonary cases in the study 
group). Next common symptom was backache (16.7%).All the 60 people had been treated with First line AKT at 
least once in the past accounting for the drug resistance. Of the 60 people, 14 people (23.3%) gave history of anti-
TB treatment for 2 times in the past. Two patients gave history of anti-TB treatment for 3 times before this second 
line regimen (Acquired Drug resistance). 
 
Table 3:X-Ray Chest findings 
 
Abnormality Frequency Percent 
     
Bilat. UZ fibrocystic 2 3.3 
Infilterates 28 46.6 
Cavitation 6 9.9 
Lt fibrocavity disease 2 3.3 
Consolidation 6 9.9 
Normal 14 23.3 
Hydropneumothorax 2 3.3 
Total 60 100.0 
      
While 14 patients had normal X-ray chest (mainly 
EPTB), the rest of the patients had X-ray findings 
consistent with pulmonary tuberculosis.  
All cases showed growth of Mycobacterium 
tuberculosis complex from the respective specimen 
sample. (i.e Sputum in Pulmonary cases) from a WHO 
accredited laboratory on AFB MGIT (Mycobacterium 
Growth in Indicator Tubes). All cases were resistant to 
Izoniazid & Rifampicin (hence they are all cases of 
Multi-drug Resistant Tuberculosis.). 
 
Discussion 
 
   It was seen that Drug Resistant Tuberculosis affects 
the economically productive age group. Males are 
generally more affected than females in Tuberculosis 
[3]. But there was a female predominance in this study 
group (63.3%). Pulmonary drug resistant cases were 
more common than extra- pulmonary cases. 42 cases 
(70%) had pulmonary TB; while 18 cases (30%) had 
Extra Pulmonary TB (EP-TB)[4].Amongst the EP-TB, 
Pott’s Spine (TB Spine) were the most common in this 
study (16.7%). All cases in this group were secondary 
drug resistant cases ( i.e all had prior exposure to anti 
TB drugs) similarly noted in Kant S et al study[5]. 
      The symptoms of tuberculosis were similar in Drug 
resistant cases but persistence of symptoms despite first 
line anti TB drugs makes one suspicious of DR- PTB. 
Similarly, in extra-pulmonary TB, failure of 
clinical/radiological response makes the diagnosis of 
possible DR- EPTB. All 60 cases were confirmed to be 
Multi-drug Resistant Tuberculosis based on WHO 
accredited laboratory for culture of Mycobacteria with 
drug susceptibility testing. Chest X-Ray and other 
imaging modalities[6]remain one of the important tools 
for diagnosis and response to treatment especially in 
extra-pulmonary cases where follow-up sample for 
microbiology is often not available while on treatment. 
 
 
Symptoms Frequency Percent 
  Constitutional symptoms 58 96.7 
Cough 38 63.3 
Backache 10 16.7 
Abscess in heel 2 3.3 
Abdominal pain 2 3.3 
Breathlessness 2 3.3 
Discharging sinus on wrist 2 3.3 
Neck swelling 2 3.3 
Right sided Chest Pain 2 3.3 
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Conclusion 
 
  Drug Resistant Tuberculosis affects the economically 
productive age-group. Constitutional symptoms 
predominate even in drug resistant tuberculosis. 
Acquired drug resistance remains the main cause for 
drug resistant tuberculosis in India. Pulmonary drug-
resistant cases exceed Extra-pulmonary cases. X-ray 
and other imaging help in diagnosis of Tuberculosis 
and also help in assessing the response to treatment. 
For follow-up in Extra-pulmonary Tuberculosis, 
Radiological modalities are mainstay for response as 
sample for culture is frequently difficult to obtain while 
on treatment. Drug Susceptibility Testing remains the 
main stay for planning treatment regimen in these 
patients. 
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